DNAJB1-PRKACA is specific for fibrolamellar carcinoma. - Wikidata - wikimedia - TriplyDB

DNAJB1-PRKACA is specific for fibrolamellar carcinoma.

DNAJB1-PRKACA is specific for fibrolamellar carcinoma.

http://www.wikidata.org/entity/Q27853135

about

Molecular pathogenesis of hepatocellular carcinoma and impact of therapeutic advances Practical aspects of NGS-based pathways analysis for personalized cancer science and medicine Hepatobiliary Tumors: Update on Diagnosis and Management CIViC database Fibrolamellar Hepatocellular Carcinoma: Mechanistic Distinction From Adult Hepatocellular Carcinoma Screening for hepatocellular carcinoma and cholangiocarcinoma: Can biomarkers replace imaging?Methylome sequencing for fibrolamellar hepatocellular carcinoma depicts distinctive features.Hepatocellular Carcinoma, Fibrolamellar Variant: Diagnostic Pathologic Criteria and Molecular Pathology Update. A Primer.A genomic case study of mixed fibrolamellar hepatocellular carcinoma Clinical implications of basic research in hepatocellular carcinoma.Comprehensive analysis of The Cancer Genome Atlas reveals a unique gene and non-coding RNA signature of fibrolamellar carcinoma.Hepatic adenomas with synchronous or metachronous fibrolamellar carcinomas: both are characterized by LFABP loss.FGFR1 and FGFR2 in fibrolamellar carcinoma.Liver Cancer: Molecular Characterization, Clonal Evolution and Cancer Stem Cells.A Proposed Physiopathological Pathway to Hyperammonemic Encephalopathy in a Non-Cirrhotic Patient with Fibrolamellar Hepatocellular Carcinoma without Ornithine Transcarbamylase (OTC) Mutation.Molecular testing for the clinical diagnosis of fibrolamellar carcinoma.Fibrolamellar Carcinoma in the Carney Complex: PRKAR1A Loss Instead of the Classic DNAJB1-PRKACA Fusion.DNAJB1-PRKACA fusion kinase interacts with β-catenin and the liver regenerative response to drive fibrolamellar hepatocellular carcinoma.CRISPR/Cas9 Engineering of Adult Mouse Liver Demonstrates That the Dnajb1-Prkaca Gene Fusion Is Sufficient to Induce Tumors Resembling Fibrolamellar Hepatocellular Carcinoma.Intracranial metastasis in fibrolamellar hepatocellular carcinoma.Gastroblastoma harbors a recurrent somatic MALAT1-GLI1 fusion gene.Tumour epithelial and stromal characteristics of hepatocellular carcinomas with abundant fibrous stroma: fibrolamellar versus scirrhous hepatocellular carcinoma.Fusion genes in solid tumors: the possibilities and the pitfalls.Non coding RNA analysis in fibrolamellar hepatocellular carcinoma.Fibrolamellar Carcinoma: Recent Advances and Unresolved Questions on the Molecular Mechanisms.Environmental exposures as a risk factor for fibrolamellar carcinoma.The DNAJB1-PRKACA chimera: Candidate biomarker and therapeutic target for fibrolamellar carcinomas.Imaging features of fibrolamellar hepatocellular carcinoma in gadoxetic acid-enhanced MRI.

P2860

2b5476b0d38698fb0d27f153ed680557c38b3f69

P248

Q26745338-E1FEE2B6-538E-4807-BD05-CC90D3C64AEE Q26748603-4F7CA326-3292-4C23-8E80-9C7B773B9C1A Q26775654-104D1C7D-D125-4688-94FE-9EC129DFA997 Q27612411-E9B0E042-1F29-4FF3-98BA-4E028CDCCFFE Q28072292-DAE631BE-C901-4730-8109-FD4F4B32BE0C Q36000994-7DCAA118-A2DC-4E2C-9C64-0509AEBA412B Q36212867-6734F454-C807-44B4-9038-5997815A30B4 Q36731897-E3F2A262-7C54-4B9E-B16E-21EE1EE5D0C1 Q36935210-ED907F1C-7A50-41F8-B007-E2AFFDD58B04 Q37289933-0F4C2F97-3FD4-460B-9F4A-927D54578069 Q38901483-DA9C9376-1EC9-43EC-A024-FA9DF8D39A5A Q39889043-FC0B5C7D-B3F8-491C-956E-FC4E334ABF7D Q40640497-C3F45CE5-317E-4363-8376-427FEAF58AAC Q41670848-637FE4B6-299D-49DD-9A35-8FF8B963C003 Q42315206-D029460E-B9E2-4AB0-A3FE-BDEFCCBD29C0 Q46447893-B9F25DF1-66B5-4760-8B20-4D377BDAE14D Q47312923-493A5A8A-3A23-4E55-B250-104A90F0DB94 Q47377422-7DF5642B-4FC7-4D43-9189-EA9B9B0640E9 Q47635386-38280F8A-5F69-4682-84F0-7402680008F7 Q47891035-212808BF-F9CF-4D9B-9F46-1A6E65AFB2CB Q48088773-B916791D-907F-46F1-9E3D-7B91EB6D80E4 Q48095053-52A65ECE-A9E4-4D61-B912-CDBC7C298151 Q51556677-C324A85C-DE9B-42E7-84BE-CDEEC1FFFB32 Q52657106-9781E911-C5A5-46C4-8C7E-1804F8AF7C65 Q52689575-862C18D8-3932-486F-A760-3105615752AB Q52897650-53089FB4-ED83-40CE-9114-0B7BA91F6488 Q54237690-6D376301-ECA3-45FF-8E6B-CC636E75B9F2 Q54264769-DC2C2B98-FF13-4689-A0CC-A038BF103BD6

P2860

DNAJB1-PRKACA is specific for fibrolamellar carcinoma.

http://www.wikidata.org/entity/Q27853135

description

2015 nî lūn-bûn

@nan

2015 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

name

DNAJB1-PRKACA is specific for fibrolamellar carcinoma.

@ast

DNAJB1-PRKACA is specific for fibrolamellar carcinoma.

@en

DNAJB1-PRKACA is specific for fibrolamellar carcinoma.

@nl

type

label

DNAJB1-PRKACA is specific for fibrolamellar carcinoma.

@ast

DNAJB1-PRKACA is specific for fibrolamellar carcinoma.

@en

DNAJB1-PRKACA is specific for fibrolamellar carcinoma.

@nl

prefLabel

DNAJB1-PRKACA is specific for fibrolamellar carcinoma.

@ast

DNAJB1-PRKACA is specific for fibrolamellar carcinoma.

@en

DNAJB1-PRKACA is specific for fibrolamellar carcinoma.

@nl

P1433

Q27853135-9AF4B3FC-3E4D-40B7-90EA-D9699CB50769

P1476

Q27853135-42171A32-EBF6-46C8-8DA9-12179911C901

P2093

Q27853135-09E47002-5CC6-494E-A277-5E90B11C3989

Q27853135-1CB00512-9608-4506-9067-ED3F9BF099B5

Q27853135-496258D1-60C4-4D46-BB35-1949EA83DE2B

Q27853135-4EFBA846-BEA6-4A49-9690-392CA2A50057

Q27853135-563A32E2-D6EB-4DBB-93EA-594EFCCDD31E

Q27853135-5AF81C05-8F3F-4374-A987-5C9CAD6FCD4B

Q27853135-5FF7CE92-FD02-4F24-92F9-3FF2692CA222

Q27853135-C8405E58-6D33-4703-A539-81EA450CABCE

Q27853135-E49AF9CA-E575-4F34-856D-D45325D535FD

Q27853135-FE34D2CE-1E4A-4842-81A9-2037309D8A31

P2860

Q27853135-00AAA712-351B-4522-9D00-2A43DF52A2AD

Q27853135-07F6CFD9-45EB-4C99-820C-A87B353E7358

Q27853135-1C4CBDA4-E5D3-4D35-A6BB-3CC62DADFD09

Q27853135-4453794C-54BA-4B0B-9B14-D9B5ADA7A909

Q27853135-4AA2D1E6-EB49-4F1E-97C3-4FFD8E0CBAE7

Q27853135-54D53429-6B85-4DD9-8A79-5341F7C92CCB

Q27853135-5617EFC7-801B-41AF-ABCC-567E71520402

Q27853135-58AAF086-B996-4472-913F-0BC23223868A

Q27853135-752FEAFB-C374-41CC-BEF5-570C5FAC13E8

Q27853135-7573D29E-F63B-46CB-87CA-211EA494B2CE

P2888

Q27853135-019BAA2C-4944-4810-B946-299D8A3EA5C6

P304

Q27853135-C408FB23-2847-4B74-AD82-2D62CD660CD3

P31

Q27853135-344504BB-E27E-4A57-ADA1-49C338911AD9

P3181

Q27853135-7D2ED48C-E2CA-4C64-9552-1BC4E4D729BA

P356

Q27853135-415792F8-812E-43E4-9171-8CC70034F8A5

P433

Q27853135-E7CD50E1-8EB2-47B4-9E78-640756E6F842

P478

Q27853135-156CA951-1576-4DAB-BEBB-A27152EC0F68

P50

Q27853135-880F8EF7-FBC5-43ED-AAE5-1AB987FA62FE

Q27853135-91B43940-343D-44BD-A953-8E6FEECD34A9

Q27853135-B606CE76-A1E2-488D-8A66-5B37D3A80DDE

P577

Q27853135-355A0708-5404-492D-B8AD-07E23E1D1B05

P5875

Q27853135-0E28D9A9-6141-4EB6-9498-F17360BB807B

P6179

Q27853135-75CAEEB5-A4E9-4B0E-B5B1-9B1825F88A1B

P698

Q27853135-D8D4CA35-A67B-4D35-BF67-90615FB82D5F

P3181

P356

MODPATHOL.2015.4

P1433

Modern Pathology

P1476

DNAJB1-PRKACA is specific for fibrolamellar carcinoma

@en

P2093

Andre M Oliveira

http://www.w3.org/2001/XMLSchema#string

Darlene L Knutson

http://www.w3.org/2001/XMLSchema#string

Kevin C Halling

http://www.w3.org/2001/XMLSchema#string

Long Jin

http://www.w3.org/2001/XMLSchema#string

Michael S Torbenson

http://www.w3.org/2001/XMLSchema#string

Nina Waldburger

http://www.w3.org/2001/XMLSchema#string

Patricia T Greipp

http://www.w3.org/2001/XMLSchema#string

Peter Schirmacher

http://www.w3.org/2001/XMLSchema#string

Sara M Kloft-Nelson

http://www.w3.org/2001/XMLSchema#string

Thomas Longerich

http://www.w3.org/2001/XMLSchema#string

P2860

Detection of a recurrent DNAJB1-PRKACA chimeric transcript in fibrolamellar hepatocellular carcinoma.

FGFR1 mRNA and protein expression, not gene copy number, predict FGFR TKI sensitivity across all lung cancer histologies.

Intracellular localization and partial amino acid sequence of a stress-inducible 40-kDa protein in HeLa cells

The gene encoding the catalytic subunit C alpha of cAMP-dependent protein kinase (locus PRKACA) localizes to human chromosome region 19p13.1

Ossifying Fibromyxoid Tumor of Soft Parts

Protein kinase A regulates MYC protein through transcriptional and post-translational mechanisms in a catalytic subunit isoform-specific manner.

Mitochondrial mutations in hepatocellular carcinomas and fibrolamellar carcinomas

Alternate protein kinase A activity identifies a unique population of stromal cells in adult bone

Chromophobe hepatocellular carcinoma with abrupt anaplasia: a proposal for a new subtype of hepatocellular carcinoma with unique morphological and molecular features.

RNAscope: a novel in situ RNA analysis platform for formalin-fixed, paraffin-embedded tissues.

P2888

modpathol.2015.4

P304

822-829

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1676278

http://www.w3.org/2001/XMLSchema#string

P356

10.1038/MODPATHOL.2015.4

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

28

http://www.w3.org/2001/XMLSchema#string

P50

Lewis R. Roberts

Rondell P Graham

Stephanie Roessler

P577

2015-02-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

272518515

http://www.w3.org/2001/XMLSchema#string

P6179

1046074811

http://www.w3.org/2001/XMLSchema#string

P698

25698061

http://www.w3.org/2001/XMLSchema#string